A. Harnett

Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.

H. Earl, J. Peto, J. Yarnold, 2007, Journal of the National Cancer Institute.

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

E. Sawyer, J. Yarnold, C. Coles, 2020, The Lancet.

Polychemotherapy for Early Breast Cancer: Results From the International Adjuvant Breast Cancer Chemotherapy Randomized Trial

Christopher Poole, Helena M. Earl, H. Earl, 2007 .

Sequential tamoxifen and megestrol acetate with continuous norethisterone in postmenopausal breast cancer: a feasibility study

D. Bissett, S. Kaye, P. Canney, 1996 .

Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapy.

D. Bissett, S. Kaye, D. Jodrell, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study

Christopher M. Kirchhoff, Stuart James, S. Cawthorn, 2019, British Journal of Cancer.